These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 19171434)

  • 1. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis.
    Shi M; Liu D; Duan H; Shen B; Guo N
    Cancer Metastasis Rev; 2010 Dec; 29(4):785-99. PubMed ID: 20938719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
    Lowery AJ; Miller N; McNeill RE; Kerin MJ
    Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
    Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is new in the biology and prognosis of breast cancer?].
    Kosma VM
    Duodecim; 2005; 121(24):2621-2. PubMed ID: 16454244
    [No Abstract]   [Full Text] [Related]  

  • 12. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
    Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
    Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells.
    Shah MY; Pan X; Fix LN; Farwell MA; Zhang B
    J Cell Physiol; 2011 Jul; 226(7):1868-78. PubMed ID: 21506117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.